about
Replimune Group Inc is a clinical-stage biotechnology company committed to applying its expertise in the field of oncolytic immunotherapy to transform the lives of cancer patients through novel oncolytic immunotherapies. Its proprietary oncolytic imm...
Read More
12.96
-0.51
(-3.79%)
1.9M
XNAS Volume
XNAS 23 Sep, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Neutral
Replimune Grp Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..